ArticleMolecular therapy. Oncology2025

Akt inhibition enhances the antitumor efficacy of immune checkpoint blockades and radiotherapy in a syngeneic breast cancer model.

Nawon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.